Cortistatin and somatostatin mRNAs are differentially regulated in response to kainate

Molecular Brain Research

Volumn 72, Issue 1, 1999, Pages 55-64

  Calbet, Marta ^a   Guadaño Ferraz, Ana ^a   Spier, Avron D ^a   Maj, Marcin ^b   Sutcliffe, J Gregor ^a   Przewłocki, Ryszard ^b   De Lecea, Luis ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Neuropeptide; Promoter analysis; Seizure; Somatostatin receptor; Transcription factor

Indexed keywords

KAINIC ACID; MESSENGER RNA; NEUROPEPTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HIPPOCAMPUS; LOCOMOTION; MOLECULAR CLONING; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEIZURE; SLOW WAVE SLEEP;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CEREBRAL CORTEX; CLONING, MOLECULAR; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; GENES; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INTERNEURONS; KAINIC ACID; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEUROPEPTIDES; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SEIZURES; SOMATOSTATIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0345493763     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00220-X     Document Type: Article

References (58)

1. Aird W.C., Parvin J.D., Sharp P.A., Rosenberg R.D. The interaction of GATA-binding proteins and basal transcription factors with GATA box-containing core promoters. A model of tissue-specific gene expression. J. Biol. Chem. 269:1994;883-889.
2. Andres V., Cervera M., Mahdavi V. Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J. Biol. Chem. 270:1995;23246-23249.
3. Andrisani O.M., Dixon J.E. Somatostatin gene regulation. Annu. Rev. Physiol. 52:1990;793-806.
4. Andrisani O.M., Hayes T.E., Roos B., Dixon J.E. Identification of the promoter sequences involved in the cell specific expression of the rat somatostatin gene. Nucleic Acids Res. 15:1987;5715-5728.
5. Araujo D.M., Lapchak P.A., Collier B., Quirion R. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus. J. Neurochem. 55:1990;1546-1555.
6. Bai G., Norton D.D., Prenger M.S., Kusiak J.W. Single-stranded DNA-binding proteins and neuron-restrictive silencer factor participate in cell-specific transcriptional control of the NMDAR1 gene. J. Biol. Chem. 273:1998;1086-1091.
7. Bessis A., Champtiaux N., Chatelin L., Changeux J.P. The neuron-restrictive silencer element: a dual enhancer/silencer crucial for patterned expression of a nicotinic receptor gene in the brain. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5906-5911.
8. Braun H., Schulz S., Becker A., Schroder H., Hollt V. Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain. Brain Res. 803:1998;54-60.
9. Conlon J.M. Somatostatin: aspects of molecular evolution. Prog. Clin. Biol. Res. 342:1990;10-15.
10. de Lecea L., Criado J.R., Prospero-Garcia O., Gautvik K.M., Schweitzer P., Danielson P.E., Dunlop C.L., Siggins G.R., Henriksen S.J., Sutcliffe J.G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature. 381:1996;242-245.
11. de Lecea L., del Rio J.A., Criado J.R., Alcantara S., Morales M., Henriksen S.J., Soriano E., Sutcliffe J.G. Cortistatin is expressed in a distinct subset of cortical interneurons. J. Neurosci. 17:1997;5868-5880.
12. de Lecea L., Ruiz-Lozano P., Danielson P., Foye P., Peelle-Kirley J., Frankel W., Sutcliffe J.G. cDNA cloning, mRNA distribution and chromosomal mapping of mouse and human preprocortistatin. Genomics. 42:1997;499-506.
13. de Lecea L., Soriano E., Criado J.R., Steffensen S.C., Henriksen S.J., Sutcliffe J.G. Transcripts encoding a neural membrane CD26 peptidase-like protein are stimulated by synaptic activity. Brain Res. Mol. Brain Res. 25:1994;286-296.
14. Dostatni N., Lambert P.F., Sousa R., Ham J., Howley P.M., Yaniv M. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev. 5:1991;1657-1671.
15. Dunlap J.C. Molecular bases for circadian clocks. Cell. 96:1999;271-290.
16. Edmondson D.G., Olson E.N. Helix-loop-helix proteins as regulators of muscle-specific transcription. J. Biol. Chem. 268:1993;755-758.
17. Forloni G., Lucca E., Angeretti N., Chiesa R., Vezzani A. Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J. Neurochem. 68:1997;319-327.
18. Fuhrmann G., Heilig R., Kempf J., Ebel A. Nucleotide sequence of the mouse preprosomatostatin gene. Nucleic Acids Res. 18:1990;1287.
19. Fukusumi S., Kitada C., Takekawa S., Kizawa H., Sakamoto J., Miyamoto M., Hinuma S., Kitano K., Fujino M. Identification and characterization of a novel human cortistatin-like peptide. Biochem. Biophys. Res. Commun. 232:1997;157-163.
20. Gall C., Lauterborn J., Isackson P., White J. Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog. Brain Res. 83:1990;371-390.
21. Goodman R.H., Jacobs J.W., Chin W.W., Lund P.K., Dee P.C., Habener J.F. Nucleotide sequence of a cloned structural gene coding for a precursor of pancreatic somatostatin. Proc. Natl. Acad. Sci. U.S.A. 77:1980;5869-5873.
22. Goodman R.H., Rehfuss R.P., Verhave M., Ventimiglia R., Low M.J. Somatostatin gene regulation: an overview. Metabolism. 39:1990;2-5.
23. Hashimoto T., Obata K. Induction of somatostatin by kainic acid in pyramidal and granule cells of the rat hippocampus. Neurosci. Res. 12:1991;514-527.
24. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., Podkolodny N.L., Kolchanov N.A. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26:1998;362-367.
25. Jin X., Shearman L.P., Weaver D.R., Zylka M.J., de Vries G.J., Reppert S.M. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell. 96:1999;57-68.
26. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9618-9622.
27. Kaufman P.D., Rio D.C. Drosophila P-element transposase is a transcriptional repressor in vitro. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2613-2617.
28. Kawana M., Lee M.E., Quertermous E.E., Quertermous T. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol. Cell Biol. 15:1995;4225-4231.
29. Kinney W.R., McNamara R.K., Valcourt E., Routtenberg A. Prolonged alteration in E-box binding after a single systemic kainate injection: potential relation to F1/GAP-43 gene expression. Brain Res. Mol. Brain Res. 38:1996;25-36.
30. Li N., Seetharam B. A 69-base pair fragment derived from human transcobalamin II promoter is sufficient for high bidirectional activity in the absence of a TATA box and an initiator element in transfected cells. Role of an E box in transcriptional activity. J. Biol. Chem. 273:1998;28170-28177.
31. Lyons G.E., Micales B.K., Schwarz J., Martin J.F., Olson E.N. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 15:1995;5727-5738.
32. Mancillas J.R., Siggins G.R., Bloom F.E. Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7518-7521.
33. McDermott J.C., Cardoso M.C., Yu Y.T., Andres V., Leifer D., Krainc D., Lipton S.A., Nadal-Ginard B. hMef2c gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell Biol. 13:1993;2564-2577.
34. Molkentin J.D., Black B.L., Martin J.F., Olson E.N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1995;1125-1136.
35. Molkentin J.D., Black B.L., Martin J.F., Olson E.N. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell Biol. 16:1996;2627-2636.
36. Molkentin J.D., Li L., Olson E.N. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 271:1996;17199-17204.
37. Montminy M.R., Goodman R.H., Horovitch S.J., Habener J.F. Primary structure of the gene encoding rat preprosomatostatin. Proc. Natl. Acad. Sci. U.S.A. 81:1984;3337-3340.
38. Nedivi E., Hevroni D., Naot D., Israeli D., Citri Y. Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature. 363:1993;718-722.
39. Ohkuma Y., Horikoshi M., Roeder R.G., Desplan C. Engrailed, a homeodomain protein, can repress in vitro transcription by competition with the TATA box-binding protein transcription factor IID. Proc. Natl. Acad. Sci. U.S.A. 87:1990;2289-2293.
40. Olenik C., Meyer D.K., Marksteiner J., Sperk G. Concentrations of mRNAs encoding for preprosomatostatin and preprocholecystokinin are increased after kainic acid-induced seizures. Synapse. 4:1989;223-228.
41. Pennypacker K.R., Thai L., Hong J.S., McMillian M.K. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14:1994;3998-4006.
42. Pennypacker K.R., Walczak D., Thai L., Fannin R., Mason E., Douglass J., Hong J.S. Kainate-induced changes in opioid peptide genes and AP-1 protein expression in the rat hippocampus. J. Neurochem. 60:1993;204-211.
43. 2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience. 65:1995;1087-1097.
44. Perez-Otano I., McMillian M.K., Chen J., Bing G., Hong J.S., Pennypacker K.R. Induction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity. Glia. 16:1996;306-315.
45. Przewlocki R., Kaminska B., Lukasiuk K., Nowicka D.Z., Przewlocka B., Kaczmarek L., Lason W. Seizure related changes in the regulation of opioid genes and transcription factors in the dentate gyrus of rat hippocampus. Neuroscience. 68:1995;73-81.
46. Schibler U., Tosi M., Pittet A.C., Fabiani L., Wellauer P.K. Tissue-specific expression of mouse alpha-amylase genes. J. Mol. Biol. 142:1980;93-116.
47. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A. Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev. 22:1996;27-50.
48. Sherwood N.M., Parker D.B. Neuropeptide families: an evolutionary perspective. J. Exp. Zool. Suppl. 4:1990;63-71.
49. 125I ]Tyr10-cortistatin14 labels all five somatostatin receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;483-489.
50. Sonnenberg J.L., Mitchelmore C., Macgregor-Leon P.F., Hempstead J., Morgan J.I., Curran T. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24:1989;72-80.
51. Su C.J., White J.W., Li W.H., Luo C.C., Frazier M.L., Saunders G.F., Chan L. Structure and evolution of somatostatin genes. Mol. Endocrinol. 2:1988;209-216.
52. Tallent M.K., Siggins G.R. Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. J. Neurophysiol. 81:1999;. in press.
53. Todisco A., Campbell V., Dickinson C.J., DelValle J., Yamada T. Molecular basis for somatostatin action: inhibition of c-fos expression and AP-1 binding. Am. J. Physiol. 267:1994;G245-G253.
54. Vallejo M., Penchuk L., Habener J.F. Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, Isl-1-like, and alpha-CBF-like transcription factors. J. Biol. Chem. 267:1992;12876-12884.
55. Veber D.F., Holly F.W., Nutt R.F., Bergstrand S.J., Brady S.F., Hirschmann R., Glitzer M.S., Saperstein R. Highly active cyclic and bicyclic somatostatin analogues of reduced ring size. Nature. 280:1979;512-514.
56. Vezzani A., Schwarzer C., Lothman E.W., Williamson J., Sperk G. Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res. 26:1996;267-279.
57. Weber J.R., Skene J.H. The activity of a highly promiscuous AP-1 element can be confined to neurons by a tissue-selective repressive element. J. Neurosci. 18:1998;5264-5274.
58. Weber J.R.M., Skene J.H.P. Identification of a novel repressive element that contributes to neuron-specific gene expression. J. Neurosci. 17:1997;7583-7593.